(R)-2-((R)-3-amino-3-(4-((2-(methoxymethyl)quinolin-4-yl)methoxy)phenyl)-2-oxopyrrolidin-1-yl)-N-hydroxypropanamide

ID: ALA3221867

PubChem CID: 90668122

Max Phase: Preclinical

Molecular Formula: C25H28N4O5

Molecular Weight: 464.52

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COCc1cc(COc2ccc([C@]3(N)CCN([C@H](C)C(=O)NO)C3=O)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C25H28N4O5/c1-16(23(30)28-32)29-12-11-25(26,24(29)31)18-7-9-20(10-8-18)34-14-17-13-19(15-33-2)27-22-6-4-3-5-21(17)22/h3-10,13,16,32H,11-12,14-15,26H2,1-2H3,(H,28,30)/t16-,25-/m1/s1

Standard InChI Key:  BJFRXYUBWYXLAN-PUAOIOHZSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   12.7669   -5.6111    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1773   -4.8940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9840   -5.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0715   -5.8887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3190   -6.2209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8408   -4.1415    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.8090   -5.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2236   -4.3512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0486   -4.3512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4591   -5.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0486   -5.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2236   -5.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2883   -5.0683    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.6986   -5.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1738   -5.7810    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.7633   -6.4938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9383   -6.4938    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5236   -5.7810    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9383   -5.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5236   -4.3512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9383   -3.6385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7633   -3.6385    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1738   -4.3512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7633   -5.0683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6506   -6.4681    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9465   -5.6944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4236   -5.0561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8233   -6.6000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.1785   -7.1185    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.8791   -7.9009    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1826   -7.2191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7642   -7.9447    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.1835   -8.6700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0716   -4.2480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  1  5  1  0
  2  6  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
  7 12  2  0
 13 14  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 15 24  1  0
 19 24  1  0
 14 18  1  0
 10 13  1  0
  3  7  1  0
 25 26  1  0
 26 27  1  1
  1 26  1  0
 25 28  2  0
 25 29  1  0
 29 30  1  0
 16 31  1  0
 31 32  1  0
 32 33  1  0
  3 34  1  1
M  END

Associated Targets(Human)

Whole blood (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.52Molecular Weight (Monoisotopic): 464.2060AlogP: 2.24#Rotatable Bonds: 8
Polar Surface Area: 127.01Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 8.75CX Basic pKa: 7.46CX LogP: 1.13CX LogD: 0.95
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.34Np Likeness Score: -0.55

References

1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P.  (2011)  Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors,  (10): [10.1039/C0MD00261E]

Source